Talaromyces marneffei: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Talaromyces marneffei''' | {{Short description|Species of fungus}} | ||
{{Taxobox | |||
| name = Talaromyces marneffei | |||
| image = Penicillium_marneffei_colony.jpg | |||
| image_caption = Colony of ''Talaromyces marneffei'' | |||
| regnum = Fungi | |||
| divisio = Ascomycota | |||
| classis = Eurotiomycetes | |||
| ordo = Eurotiales | |||
| familia = Trichocomaceae | |||
| genus = ''Talaromyces'' | |||
| species = '''''T. marneffei''''' | |||
| binomial = ''Talaromyces marneffei'' | |||
| binomial_authority = (Segretain) Samson, N. Yilmaz & Frisvad | |||
}} | |||
'''''Talaromyces marneffei''''', formerly known as '''''Penicillium marneffei''''', is a [[dimorphic fungus]] endemic to Southeast Asia. It is a significant [[opportunistic pathogen]] in [[immunocompromised]] individuals, particularly those with [[HIV/AIDS]]. | |||
==Morphology== | |||
''Talaromyces marneffei'' exhibits [[dimorphism]], meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing characteristic greenish colonies with a red pigment that diffuses into the medium. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans. | |||
== | ==Pathogenesis== | ||
''Talaromyces marneffei'' infection, known as [[talaromycosis]], occurs primarily in individuals with weakened immune systems. The fungus is inhaled as spores, which then convert to the yeast form in the body, leading to systemic infection. Symptoms include fever, weight loss, and respiratory issues, often resembling [[tuberculosis]] or [[histoplasmosis]]. | |||
''Talaromyces marneffei'' is | ==Diagnosis== | ||
Diagnosis of ''Talaromyces marneffei'' infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Microscopic examination can reveal the characteristic yeast cells with transverse septa. | |||
== | ==Treatment== | ||
The treatment of choice for talaromycosis is [[amphotericin B]], followed by [[itraconazole]] for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and mortality. | |||
''Talaromyces marneffei'' | ==Epidemiology== | ||
''Talaromyces marneffei'' is endemic to regions of Southeast Asia, including Thailand, Vietnam, and southern China. It is associated with bamboo rat habitats, although the exact ecological niche and mode of transmission to humans remain under investigation. | |||
== | ==Prevention== | ||
Preventive measures for talaromycosis include avoiding exposure to environments where the fungus is endemic, particularly for individuals with compromised immune systems. Prophylactic antifungal therapy may be considered for high-risk patients. | |||
==Related pages== | |||
* [[Fungal infection]] | |||
== | * [[Opportunistic infection]] | ||
* [[ | |||
* [[ | |||
* [[HIV/AIDS]] | * [[HIV/AIDS]] | ||
* [[Amphotericin B]] | |||
[[Category: | * [[Itraconazole]] | ||
[[Category: | [[Category:Talaromyces|marneffei]] | ||
[[Category: | [[Category:Dimorphic fungi]] | ||
[[Category:Opportunistic pathogens]] | |||
[[Category:Fungi described in 1956]] | |||
Latest revision as of 14:44, 22 February 2025
Species of fungus
Talaromyces marneffei, formerly known as Penicillium marneffei, is a dimorphic fungus endemic to Southeast Asia. It is a significant opportunistic pathogen in immunocompromised individuals, particularly those with HIV/AIDS.
Morphology[edit]
Talaromyces marneffei exhibits dimorphism, meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing characteristic greenish colonies with a red pigment that diffuses into the medium. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans.
Pathogenesis[edit]
Talaromyces marneffei infection, known as talaromycosis, occurs primarily in individuals with weakened immune systems. The fungus is inhaled as spores, which then convert to the yeast form in the body, leading to systemic infection. Symptoms include fever, weight loss, and respiratory issues, often resembling tuberculosis or histoplasmosis.
Diagnosis[edit]
Diagnosis of Talaromyces marneffei infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Microscopic examination can reveal the characteristic yeast cells with transverse septa.
Treatment[edit]
The treatment of choice for talaromycosis is amphotericin B, followed by itraconazole for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and mortality.
Epidemiology[edit]
Talaromyces marneffei is endemic to regions of Southeast Asia, including Thailand, Vietnam, and southern China. It is associated with bamboo rat habitats, although the exact ecological niche and mode of transmission to humans remain under investigation.
Prevention[edit]
Preventive measures for talaromycosis include avoiding exposure to environments where the fungus is endemic, particularly for individuals with compromised immune systems. Prophylactic antifungal therapy may be considered for high-risk patients.
